kPNI und Forschung

Liebe Patien­tIn­nen, liebe KlientInnen,

auf dieser Seite gebe ich Ihnen einen kleinen Einblick in wissen­schaft­li­che Paper zu kPNI- relevan­ten Themen.

  1. “The opioid effects of gluten exorphins: asympto­ma­tic celiac disea­se.”
    Leo Pruim­boom and Karin de Punder
    Journal of Health, Popula­ti­on and Nutri­ti­on 2015 33:24
    Veröf­fent­licht am 24.11.2015
  2. “Zonulin and its regula­ti­on of intesti­nal barri­er function: the biolo­gi­cal door to inflamm­a­ti­on, autoim­mu­ni­ty, and cancer.”
    Fasano A
    Physi­ol Rev. 2011 Jan;91(1):151-75. doi: 10.1152/physrev.00003.2008.
  3. “Stress Induces Endoto­xe­mia and Low-Grade Inflamm­a­ti­on by Incre­asing Barri­er Permeability.”
    Karin de Punder and Leo Pruimboom
  4. “Preva­lence of Anti-Neu5Gc Antibo­dies in Patients with Hypothyroidism.”
    Phaedra Eleft­he­riou, Stavros Kynigo­pou­los, Alexan­dra Giovou, Alexan­dra Mazma­ni­di, John Yovos, Petros Skepas­tia­nos, Eleni Vagdat­li, Chris­tos Petrou, Dafni Papara, and Maria Efterpiou1
  5. “Chronic pain: a non-use diseas”
    Pruim­boom L, van Dam AC
    Medical hypothe­ses 2007;68(3):506-11Epub 2006 Oct 30.
  6. “The role of the gut micro­bio­ta in energy metabo­lism and metabo­lic disease”
    Cani PD, Delzen­ne NM
    Curr Pharm Des. 2009;15(13):1546-58
  7. “Fructo­se, insulin resis­tance, and metabo­lic dyslipidemia.”
    Bascia­no H, Feder­i­co L, Adeli K
    Nutr Metab (Lond). Feb 21;2(1):5.
  8. “Fructo­se: a key factor in the develo­p­ment of metabo­lic syndro­me and hypertension.”
    Khitan Z, Kim DH
    J Nutr Metab. 2013;2013:682673. doi: 10.1155/2013/682673. Epub 2013 May 25
  9. “Insulin resis­tance and skin disea­ses.” M Napoli­ta­no, M Megna, G Monfre­co­la - The Scien­ti­fic World Journal, 2015
  10.  “Use of bovine lactof­er­rin for Helico­bac­ter pylori eradi­ca­ti­on” Di Mario, Dig Liver Dis. 2003 Oct;35(10):706-10.